Guido Lanza
Chief Executive Officer
John Griffin, Ph.D.
Chief Scientific Officer
Brandon Allgood, Ph.D.
Chief Technology Officer
Nigel Duffy, Ph.D.
Technology Strategy
Kevin Kaster
IP Strategy

We seek to overcome the major challenges in drug discovery and next generation sequencing with our data analytics platform.

Guido Lanza is the President and CEO of Numerate. Formerly, Guido was the co-founder and Chief Technical Officer of Pharmix, where he served on the company's Board of Directors for five years and was named one of Business Week's "Tech's Best Young Entrepreneurs under-30" in 2006. Prior to Pharmix, Guido was a research scientist with Professor Koza of Stanford University with whom he developed applications of genetic programming in the area of bioinformatics and computational biology. Guido is the author of 10 scientific publications and inventor of 4 issued patents. He received a B.A. in Molecular and Cell Biology and Integrative Biology from the University of California, Berkeley and an M.Sc. in Bioinformatics from the University of Manchester (UK).

Numerate